While Aurinia Pharmaceuticals insiders bought shares during the last year, they didn't sell. Their average price was about US$6.57. To my mind it is good that insiders have invested their own money in the company. However, we do note that they were buying at significantly lower prices than today's share price. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below! NasdaqGM:AUPH Insider Trading Volume March 8th 2023